Regencell Bioscience Holdings Stock Price Prediction

RGC Stock  USD 5.65  0.05  0.88%   
At the present time, The RSI of Regencell Bioscience's share price is at 54 indicating that the stock is in nutural position, most likellhy at or near its resistance level. The main idea of RSI analysis is to track how fast people are buying or selling Regencell Bioscience, making its price go up or down.

Oversold Vs Overbought

54

 
Oversold
 
Overbought
The successful prediction of Regencell Bioscience's future price could yield a significant profit. We analyze noise-free headlines and recent hype associated with Regencell Bioscience Holdings, which may create opportunities for some arbitrage if properly timed.
Using Regencell Bioscience hype-based prediction, you can estimate the value of Regencell Bioscience Holdings from the perspective of Regencell Bioscience response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Regencell Bioscience to buy its stock at a price that has no basis in reality. In that case, they are not buying Regencell because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.

Regencell Bioscience after-hype prediction price

    
  USD 5.65  
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
  
Check out Regencell Bioscience Basic Forecasting Models to cross-verify your projections.
Intrinsic
Valuation
LowRealHigh
0.254.9914.48
Details
Naive
Forecast
LowNextHigh
0.094.4913.98
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
4.396.348.28
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Regencell Bioscience. Your research has to be compared to or analyzed against Regencell Bioscience's peers to derive any actionable benefits. When done correctly, Regencell Bioscience's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Regencell Bioscience.

Regencell Bioscience After-Hype Price Prediction Density Analysis

As far as predicting the price of Regencell Bioscience at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Regencell Bioscience or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Regencell Bioscience, with the unreliable approximations that try to describe financial returns.
   Next price density   
       Expected price to next headline  

Regencell Bioscience Estimiated After-Hype Price Volatility

In the context of predicting Regencell Bioscience's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Regencell Bioscience's historical news coverage. Regencell Bioscience's after-hype downside and upside margins for the prediction period are 0.28 and 15.14, respectively. We have considered Regencell Bioscience's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
5.65
5.65
After-hype Price
15.14
Upside
Regencell Bioscience is very risky at this time. Analysis and calculation of next after-hype price of Regencell Bioscience is based on 3 months time horizon.

Regencell Bioscience Stock Price Prediction Analysis

Have you ever been surprised when a price of a Company such as Regencell Bioscience is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Regencell Bioscience backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Regencell Bioscience, there might be something going there, and it might present an excellent short sale opportunity.
Expected ReturnPeriod VolatilityHype ElasticityRelated ElasticityNews DensityRelated DensityExpected Hype
  0.17 
9.49
  0.04 
 0.00  
12 Events / Month
6 Events / Month
In about 12 days
Latest traded priceExpected after-news pricePotential return on next major newsAverage after-hype volatility
5.65
5.65
0.00 
4,519  
Notes

Regencell Bioscience Hype Timeline

On the 22nd of November Regencell Bioscience is traded for 5.65. The entity has historical hype elasticity of -0.04, and average elasticity to hype of competition of 0.0. Regencell is forecasted not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is over 100%. The immediate return on the next news is forecasted to be very small, whereas the daily expected return is at this time at -0.17%. %. The volatility of related hype on Regencell Bioscience is about 33134.11%, with the expected price after the next announcement by competition of 5.65. About 89.0% of the company outstanding shares are owned by corporate insiders. The company has Price/Earnings To Growth (PEG) ratio of 2.15. Regencell Bioscience recorded a loss per share of 0.33. The entity last dividend was issued on the 1st of December 2017. Considering the 90-day investment horizon the next forecasted press release will be in about 12 days.
Check out Regencell Bioscience Basic Forecasting Models to cross-verify your projections.

Regencell Bioscience Related Hype Analysis

Having access to credible news sources related to Regencell Bioscience's direct competition is more important than ever and may enhance your ability to predict Regencell Bioscience's future price movements. Getting to know how Regencell Bioscience's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Regencell Bioscience may potentially react to the hype associated with one of its peers.
Hype
Elasticity
News
Density
Semi
Deviation
Information
Ratio
Potential
Upside
Value
At Risk
Maximum
Drawdown
DLTNFDelta 9 Cannabis 0.00 0 per month 0.00  0.00  0.00  0.00  0.00 
RAMMFRAMM Pharma Corp 0.00 0 per month 0.00  0.00  0.00  0.00  0.00 
CVGRFCity View Green 0.00 0 per month 0.00  0.08  0.00  0.00  95.65 
BHHKFBenchmark Botanics 0.00 0 per month 0.00  0.00  0.00  0.00  0.00 
SPBBFSpeakeasy Cannabis Club 0.00 0 per month 0.00  0.00  0.00  0.00  0.00 
PROCWProcaps Group SA(0.01)2 per month 0.00 (0.08) 26.79 (32.09) 78.66 
SSICSilver Spike Investment(0.20)6 per month 1.04  0.04  2.89 (1.82) 7.09 
EGRXEagle Pharmaceuticals 0.00 0 per month 0.00 (0.19) 9.24 (8.24) 53.71 
PAHCPhibro Animal Health 0.49 10 per month 1.63  0.12  5.36 (2.45) 15.47 
SBFMWSunshine Biopharma Warrant 0.02 1 per month 14.88  0.17  50.00 (28.00) 103.27 
COSMCosmos Health(0.05)8 per month 0.00 (0.16) 6.85 (7.89) 27.64 
ACRXAcelRx Pharmaceuticals 0.02 1 per month 4.26  0.07  13.85 (8.26) 29.52 
HEXOHexo Corp 0.05 8 per month 0.00 (0.12) 5.88 (10.47) 56.99 
PBHPrestige Brand Holdings(0.08)9 per month 0.91  0.14  1.90 (1.76) 4.90 
COLLCollegium Pharmaceutical(0.86)9 per month 0.00 (0.14) 3.59 (4.47) 12.29 
ANIPANI Pharmaceuticals 0.21 11 per month 0.00 (0.1) 3.70 (3.75) 10.82 
PROCProcaps Group SA(0.08)2 per month 0.00 (0.02) 8.74 (12.37) 63.61 

Regencell Bioscience Additional Predictive Modules

Most predictive techniques to examine Regencell price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Regencell using various technical indicators. When you analyze Regencell charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

About Regencell Bioscience Predictive Indicators

The successful prediction of Regencell Bioscience stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Regencell Bioscience Holdings, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Regencell Bioscience based on analysis of Regencell Bioscience hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Regencell Bioscience's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Regencell Bioscience's related companies.
 2023 2024 (projected)
Interest Debt Per Share13.6214.3
Revenue Per Share23.2722.1

Story Coverage note for Regencell Bioscience

The number of cover stories for Regencell Bioscience depends on current market conditions and Regencell Bioscience's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Regencell Bioscience is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Regencell Bioscience's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.

Regencell Bioscience Short Properties

Regencell Bioscience's future price predictability will typically decrease when Regencell Bioscience's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Regencell Bioscience Holdings often depends not only on the future outlook of the potential Regencell Bioscience's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Regencell Bioscience's indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding13 M
Cash And Short Term InvestmentsM

Complementary Tools for Regencell Stock analysis

When running Regencell Bioscience's price analysis, check to measure Regencell Bioscience's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Regencell Bioscience is operating at the current time. Most of Regencell Bioscience's value examination focuses on studying past and present price action to predict the probability of Regencell Bioscience's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Regencell Bioscience's price. Additionally, you may evaluate how the addition of Regencell Bioscience to your portfolios can decrease your overall portfolio volatility.
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account